{"pmid":32347602,"title":"Should we try the antiinflammatory natural product, celastrol, for COVID-19?","text":["Should we try the antiinflammatory natural product, celastrol, for COVID-19?","Phytother Res","Habtemariam, Solomon","Nabavi, Seyed Fazel","Berindan-Neagoe, Ioana","Cismaru, Cosmin Andrei","Izadi, Morteza","Sureda, Antoni","Nabavi, Seyed Mohammad","32347602"],"journal":"Phytother Res","authors":["Habtemariam, Solomon","Nabavi, Seyed Fazel","Berindan-Neagoe, Ioana","Cismaru, Cosmin Andrei","Izadi, Morteza","Sureda, Antoni","Nabavi, Seyed Mohammad"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347602","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/ptr.6711","e_drugs":["tripterine"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1665441658296074241,"score":8.599203,"similar":[{"pmid":32340551,"title":"Natural products may interfere with SARS-CoV-2 attachment to the host cell.","text":["Natural products may interfere with SARS-CoV-2 attachment to the host cell.","Objectives: SARS-CoV-2 has been emerged in December 2019 in China, causing deadly (5% mortality) pandemic pneumonia, termed COVID-19. More than one host-cell receptor is reported to be recognized by the viral spike protein, among them is the cell-surface Heat Shock Protein A5 (HSPA5), also termed GRP78 or BiP. Upon viral infection, HSPA5 is upregulated, then translocating to the cell membrane where it is subjected to be recognized by the SARS-CoV-2 spike. In this study, some natural product compounds are tested against the HSPA5 substrate-binding domain beta (SBDbeta), which reported to be the recognition site for the SARS-CoV-2 spike.Methods: Molecular docking and molecular dynamics simulations are used to test some natural compounds binding to HSPA5 SBDbeta.Results: The results show high to a moderate binding affinity for the phytoestrogens (Diadiazin, Genistein, Formontein, and Biochanin A), chlorogenic acid, linolenic acid, palmitic acid, caffeic acid, caffeic acid phenethyl ester, hydroxytyrosol, cis-p-Coumaric acid, cinnamaldehyde, thymoquinone, and some physiological hormones such as estrogens, progesterone, testosterone, and cholesterol to the HSPA5 SBDbeta. Based on its binding affinities, the phytoestrogens and estrogens are the best in binding HSPA5, hence may interfere with SARS-CoV-2 attachment to the stressed cells.Conclusion: These compounds can be successful as anti-COVID-19 agents for people with a high risk of cell stress like elders, cancer patients, and front-line medical staff.","J Biomol Struct Dyn","Elfiky, Abdo A","32340551"],"abstract":["Objectives: SARS-CoV-2 has been emerged in December 2019 in China, causing deadly (5% mortality) pandemic pneumonia, termed COVID-19. More than one host-cell receptor is reported to be recognized by the viral spike protein, among them is the cell-surface Heat Shock Protein A5 (HSPA5), also termed GRP78 or BiP. Upon viral infection, HSPA5 is upregulated, then translocating to the cell membrane where it is subjected to be recognized by the SARS-CoV-2 spike. In this study, some natural product compounds are tested against the HSPA5 substrate-binding domain beta (SBDbeta), which reported to be the recognition site for the SARS-CoV-2 spike.Methods: Molecular docking and molecular dynamics simulations are used to test some natural compounds binding to HSPA5 SBDbeta.Results: The results show high to a moderate binding affinity for the phytoestrogens (Diadiazin, Genistein, Formontein, and Biochanin A), chlorogenic acid, linolenic acid, palmitic acid, caffeic acid, caffeic acid phenethyl ester, hydroxytyrosol, cis-p-Coumaric acid, cinnamaldehyde, thymoquinone, and some physiological hormones such as estrogens, progesterone, testosterone, and cholesterol to the HSPA5 SBDbeta. Based on its binding affinities, the phytoestrogens and estrogens are the best in binding HSPA5, hence may interfere with SARS-CoV-2 attachment to the stressed cells.Conclusion: These compounds can be successful as anti-COVID-19 agents for people with a high risk of cell stress like elders, cancer patients, and front-line medical staff."],"journal":"J Biomol Struct Dyn","authors":["Elfiky, Abdo A"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340551","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1080/07391102.2020.1761881","keywords":["covid-19","grp78","hspa5","molecular dynamics simulation","natural compounds","peptide-protein docking"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Testosterone","Genistein","Palmitic Acid","3,4-dihydroxyphenylethanol","Cholesterol","Chlorogenic Acid","Progesterone","caffeic acid phenethyl ester","caffeic acid","cinnamic aldehyde","alpha-Linolenic Acid","thymoquinone"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1665351883971100672,"score":102.04324},{"pmid":32248575,"title":"Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.","text":["Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.","Several corona viral infections have created serious threats in the last couple of decades claiming the death of thousands of human beings. Recently, corona viral epidemic raised the issue of developing effective antiviral agents at the earliest to prevent further losses. Natural products have always played a crucial role in drug development process against various diseases, which resulted in screening of such agents to combat emergent mutants of corona virus. This review focuses on those natural compounds that showed promising results against corona viruses. Although inhibition of viral replication is often considered as a general mechanism for antiviral activity of most of the natural products, studies have shown that some natural products can interact with key viral proteins that are associated with virulence. In this context, some of the natural products have antiviral activity in the nanomolar concentration (e.g., lycorine, homoharringtonine, silvestrol, ouabain, tylophorine, and 7-methoxycryptopleurine) and could be leads for further drug development on their own or as a template for drug design. In addition, a good number of natural products with anti-corona virus activity are the major constituents of some common dietary supplements, which can be exploited to improve the immunity of the general population in certain epidemics.","Phytother Res","Islam, Muhammad T","Sarkar, Chandan","El-Kersh, Dina M","Jamaddar, Sarmin","Uddin, Shaikh J","Shilpi, Jamil A","Mubarak, Mohammad S","32248575"],"abstract":["Several corona viral infections have created serious threats in the last couple of decades claiming the death of thousands of human beings. Recently, corona viral epidemic raised the issue of developing effective antiviral agents at the earliest to prevent further losses. Natural products have always played a crucial role in drug development process against various diseases, which resulted in screening of such agents to combat emergent mutants of corona virus. This review focuses on those natural compounds that showed promising results against corona viruses. Although inhibition of viral replication is often considered as a general mechanism for antiviral activity of most of the natural products, studies have shown that some natural products can interact with key viral proteins that are associated with virulence. In this context, some of the natural products have antiviral activity in the nanomolar concentration (e.g., lycorine, homoharringtonine, silvestrol, ouabain, tylophorine, and 7-methoxycryptopleurine) and could be leads for further drug development on their own or as a template for drug design. In addition, a good number of natural products with anti-corona virus activity are the major constituents of some common dietary supplements, which can be exploited to improve the immunity of the general population in certain epidemics."],"journal":"Phytother Res","authors":["Islam, Muhammad T","Sarkar, Chandan","El-Kersh, Dina M","Jamaddar, Sarmin","Uddin, Shaikh J","Shilpi, Jamil A","Mubarak, Mohammad S"],"date":"2020-04-06T11:00:00Z","year":2020,"_id":"32248575","week":"202015|Apr 06 - Apr 12","doi":"10.1002/ptr.6700","keywords":["coronavirus","humans health","phytochemicals"],"source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"e_drugs":["silvestrol","Ouabain","tylophorine","Homoharringtonine","lycorine","7-methoxycryptopleurine"],"_version_":1664637850794065921,"score":95.559395},{"pmid":32340389,"title":"Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.","text":["Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.","The current emergency due to the worldwide spread of the COVID-19 caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a great concern for global public health. Already in the past, the outbreak of severe acute respiratory syndrome (SARS) in 2003 and Middle Eastern respiratory syndrome (MERS) in 2012 demonstrates the potential of coronaviruses to cross-species borders and further underlines the importance of identifying new-targeted drugs. An ideal antiviral agent should target essential proteins involved in the lifecycle of SARS-CoV. Currently, some HIV protease inhibitors (i.e., Lopinavir) are proposed for the treatment of COVID-19, although their effectiveness has not yet been assessed. The main protease (M(pr)) provides a highly validated pharmacological target for the discovery and design of inhibitors. We identified potent M(pr) inhibitors employing computational techniques that entail the screening of a Marine Natural Product (MNP) library. MNP library was screened by a hyphenated pharmacophore model, and molecular docking approaches. Molecular dynamics and re-docking further confirmed the results obtained by structure-based techniques and allowed this study to highlight some crucial aspects. Seventeen potential SARS-CoV-2 M(pr) inhibitors have been identified among the natural substances of marine origin. As these compounds were extensively validated by a consensus approach and by molecular dynamics, the likelihood that at least one of these compounds could be bioactive is excellent.","Mar Drugs","Gentile, Davide","Patamia, Vincenzo","Scala, Angela","Sciortino, Maria Teresa","Piperno, Anna","Rescifina, Antonio","32340389"],"abstract":["The current emergency due to the worldwide spread of the COVID-19 caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a great concern for global public health. Already in the past, the outbreak of severe acute respiratory syndrome (SARS) in 2003 and Middle Eastern respiratory syndrome (MERS) in 2012 demonstrates the potential of coronaviruses to cross-species borders and further underlines the importance of identifying new-targeted drugs. An ideal antiviral agent should target essential proteins involved in the lifecycle of SARS-CoV. Currently, some HIV protease inhibitors (i.e., Lopinavir) are proposed for the treatment of COVID-19, although their effectiveness has not yet been assessed. The main protease (M(pr)) provides a highly validated pharmacological target for the discovery and design of inhibitors. We identified potent M(pr) inhibitors employing computational techniques that entail the screening of a Marine Natural Product (MNP) library. MNP library was screened by a hyphenated pharmacophore model, and molecular docking approaches. Molecular dynamics and re-docking further confirmed the results obtained by structure-based techniques and allowed this study to highlight some crucial aspects. Seventeen potential SARS-CoV-2 M(pr) inhibitors have been identified among the natural substances of marine origin. As these compounds were extensively validated by a consensus approach and by molecular dynamics, the likelihood that at least one of these compounds could be bioactive is excellent."],"journal":"Mar Drugs","authors":["Gentile, Davide","Patamia, Vincenzo","Scala, Angela","Sciortino, Maria Teresa","Piperno, Anna","Rescifina, Antonio"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340389","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3390/md18040225","keywords":["covid-19","sars-cov-2","docking","marine natural product","virtual screening"],"e_drugs":["Lopinavir"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1665351883959566336,"score":83.514015},{"pmid":32325124,"title":"Vaporization, bioactive formulations and a marine natural product: different perspectives on antivirals.","text":["Vaporization, bioactive formulations and a marine natural product: different perspectives on antivirals.","This article examines three aspects of antivirals as they might relate to the treatment of COVID-19: (i) the use of vaporization for the delivery of antivirals, with the bulk constituents having mild antiviral efficacy; (ii) the application of a marine natural product extract as opposed to a single molecule as an antiviral agent; and (iii) a counter intuitive approach to formulation that is, in part, based on delivering multiple species that fall into three categories: building blocks for the virus to accelerate replication; an energy source for the infected cell to boast its immune response; and the species that antagonize or provide toxicity to the virus.","Drug Discov Today","Manning, Thomas J","Thomas-Richardson, Jenu","Cowan, Matthew","Beard, Torien","32325124"],"abstract":["This article examines three aspects of antivirals as they might relate to the treatment of COVID-19: (i) the use of vaporization for the delivery of antivirals, with the bulk constituents having mild antiviral efficacy; (ii) the application of a marine natural product extract as opposed to a single molecule as an antiviral agent; and (iii) a counter intuitive approach to formulation that is, in part, based on delivering multiple species that fall into three categories: building blocks for the virus to accelerate replication; an energy source for the infected cell to boast its immune response; and the species that antagonize or provide toxicity to the virus."],"journal":"Drug Discov Today","authors":["Manning, Thomas J","Thomas-Richardson, Jenu","Cowan, Matthew","Beard, Torien"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32325124","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.drudis.2020.04.010","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664895932848668672,"score":79.73216},{"pmid":32344312,"title":"Potential effect of natural and anabolizan steroids in elderly patient with COVID-19.","text":["Potential effect of natural and anabolizan steroids in elderly patient with COVID-19.","Med Hypotheses","Karaahmet, Fatih","Karaahmet, Ozgur Zeliha","32344312"],"journal":"Med Hypotheses","authors":["Karaahmet, Fatih","Karaahmet, Ozgur Zeliha"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32344312","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.mehy.2020.109772","keywords":["covid-19","elderly patient","steroids"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1665351883913428992,"score":66.298744}]}